Strong Revenue Growth:
Revenue is accelerating with consistent year-over-year gains and guidance pointing to continued expansion through 2026. Record platform activity and rising deal momentum reinforce top-line trajectory.
Customer Loyalty & Retention:
Net dollar retention has improved alongside growth in core genomics customers, indicating expanding usage among existing accounts. Record analyses and repeat adoption across cohorts suggest durable engagement.
Market Expansion:
Expansion in the U.S. and APAC and the addition of large integrated health systems support a broader geographic and enterprise footprint. Increasing uptake of newer applications strengthens presence across regions.
